Clinical Trials Browser

Interventional × Plasmacytoma × Lenalidomide × Clear all

NCT03031730 2026-02-10

Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma

Phase 1 Terminated

35 enrolled 10 charts

Multiple Myeloma, Plasmacytoma

NCT04174196 2025-12-02

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

Phase 2 Active not recruiting

Multiple Myeloma, Plasmacytoma

NCT02544308 2022-12-23

IDRIS

Phase 3 Active not recruiting

Plasmacytoma